Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial

Digestive Diseases and Sciences

Volumn 50, Issue 6, 2005, Pages 1107-1112

  Parisi, Giancarlo ^a   Bottona, Enrico ^b   Carrara, Maurizio ^c   Cardin, Fabrizio ^a   Faedo, Alessandra ^b   Goldin, Dario ^d   Marino, Marco ^e   Pantalena, Maurizio ^b   Tafner, Gianni ^f   Verdianelli, Giorgio ^g   Zilli, Maurizio ^e   Leandro, Gioacchino ^h  

^a ULSS 16   (Italy)

^b UO Medicina Arzignano ^*  (Italy)

^c ASL 22   (Italy)

^d Ospedale Villa Salus   (Italy)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^f Gastroenterologia   (Italy)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^h NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Irritable bowel syndrome; Open trial; Partially hydrolyzed guar gum

Indexed keywords

GUAR GUM; NOVAFIBRA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; PATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SYMPTOM; TREATMENT OUTCOME;

ADULT; DIETARY FIBER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GALACTANS; HEALTH STATUS INDICATORS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MANNANS; MIDDLE AGED; PLANT GUMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 20844461853     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2713-7     Document Type: Article

References (41)

1. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd ed. McLean, Degnon Associates, 2000
2. American Gastroenterological Association: AGA technical review on irritable bowel syndrome. Gastroenterology 123:2108-2131, 2002
3. Camilleri M: Management of the irritable bowel syndrome. Gastroenterology 120:652-668, 2001
4. Sperling MS, McQuaid KR: Rational medical therapy of functional GI disorders. In Handbook of Functional Gastrointestinal Disorders. Olden KW (ed). New York, Marcel Dekker, 1996, pp 269-328
5. Akehurst R, Kaltenhaler E: Treatment of irritable bowel syndrome: A review of randomized controlled trials. Gut 48:272-282, 2001
6. Jenkins DJA, Leeds AR, Slavin B, Mann J, Jepson EM: Dietary fiber and blood lipids: Reduction of serum cholesterol in type II hyperlipidemia by guar gum. Am J Clin Nutr 32:16-18, 1979
7. Jenkins DJA, Goff DV, Leeds, AR, Alberti KG, Wolever TM, Gassull MA, Hockaday TD: Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycemia. Lancet 2:172-174, 1976
8. Takahashi H, Yang SI, Hayashi C, Kim M, Yamanaka J, Yamamoto T: Effect of partially hydrolyzed guar gum on fecal output in human volunteers. Nutr Res 13:649-657, 1993
9. Takanishi H, Wako N, Okubo T, Ishihara N, Yamanaka J: Influence of partially hydrolyzed guar gum on constipation in women. J Nutr Sci Vitaminol 40:251-259, 1994
10. Yamatoya K, Kuwano K, Suzuki J, Mitamura T, Sekeiya K: Effect of hydrolyzed guar gum on frequency and feeling of defecation in humans. J Appl Glycosci 42:251-257, 1995
11. Parisi GC, Zilli M, Miani MP, Bottona E, Verdianelli G, Battaglia G, Desideri S, Faedo A, Marzolino C, Tonon A, Ermani M, Leandro G: High-fiber diet supplementation in patients with irritable bowel syndrome (IBS). Comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci 47:1697-1704, 2002
12. Svedlund J, Sjödin I, Dotevall G: GSRS. A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134, 1988
13. Wiklund I: Aspects of quality of life in gastrointestinal disease: Some methodological issues. Scand J Gastroenterol 30(Suppl 208):129-132, 1993
14. Ware JE: SF-36 Health Survey. Manual and Interpretation Guide. Boston, Health Institute, New England Medical Center, 1993
15. Apolone G, Moscati P, Ware JE: Questionario sullo stato di salute SF-36. Manuale d'uso e guida all'interpretazione dei risultati. Milano, Italy, Guerinieass., 1997
16. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370, 1983
17. Hermann C: International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 42:17-41, 1997
18. Johnston M, Pollard B, Hennessey P: Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579-584, 2000
19. Farthing MJG: Irritable bowel syndrome: New pharmaceutical approaches to treatment. Balliere's Clin Gastroenterol 13:461-171, 1999
20. Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 112:2120-2137, 1997
21. Talley NJ, Working Team for Design of Treatment Trials: Optimal design of treatment trials. In The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus Drossman DA (ed). Boston, Little, Brown, 1994, pp 265-310
22. Veldhuyzen van Zanten SJO, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR: Design of treatment trials for functional gastrointestinal disorders. Gut 45(Suppl II):69-77, 1999
23. Koloski NA, Talley NJ, Boyce PM: The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67-71, 2000
24. Whitehead WE, Burnett CK, Cook III EW, Taub E: Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 41:2248-2253, 1996
25. Strassels SA, Hahyn BA: Short form 36 (SF-36) in patients with IBS compared with US norms (abstr). Gastroenterology 112(Suppl):A44, 1997
26. Wells NEJ, Hahn BA, Whorwell PJ: Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther 11:1019-1030, 1997
27. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119:654-660, 2000
28. Frank L, Kleinman L, Rentz A, et al.: Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24:675-689, 2002
29. El Serag HB, Olden K, Bjorkman D: Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16:1171-1185, 2002
30. Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU: Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry 62(Suppl. 8):48-51, 2001
31. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI, Jia H: What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 95:974-980, 2000
32. North CS, Alpers DH: Prevalence of irritable bowel syndrome in a psychiatric patient population. In Functional Dyspepsia and Irritable Bowel Syndrome. Concepts and Controversies. Goebell H, Holtmann G, Talley NJ (eds). London, Kluwer, 1998, pp 205-209
33. Porcelli P, Affatati V, Bellomo A, De Carne M, Todarello O, Taylor GJ: Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders. Psychother Psychosom 73:84-91, 2004
34. Ide T, Moriuchi H, Nihimoto K: Hypolipidemic effects of guar gum and its enzyme hydrolysate in rats fed highly saturated fat diets. Ann Nutr Metab 35:34-44, 1991
35. Takahashi H, Yank SI, Kim M, Yamamoto T: Protein and energy utilization of growing rats fed on the diets containing intact or partially hydrolyzed guar gum. Comp Biochem Physiol 107:255-260, 1994
36. Takeno F, Yamada H, Sekiya K, Fujitani B, Ohtsu K: Effect of partially decomposed guar gum on high-cholesterol-fed rats and non-dietary fiber-fed rats. J Jpn Soc Nutr Food Sci 43:421-425, 1990
37. Yamatoya K, Sekiya K, Yamada H: Effects of partially hydrolyzed guar gum on postprandial plasma glucose and lipid levels in humans. J Jpn Soc Nutr Food Sci 46:199-203, 1993
38. Okubo T, Ishihara N, Takahashi H, Fujisawa T, Kim M, Yamamoto T, Mitsouka T: Effects of partially hydrolyzed guar gum intake on human intestinal microflora and its metabolism. Biosci Biotech Biochem 58:1364-1369, 1994
39. Cummings JH, Southgate DAT, Branch W, Houston H, Jenskins DJA, James WPT: Colonie response to dietary fiber from carrot, cabbage, apple, bran and guar gum. Lancet 1:5-9, 1978
40. Penagini R, Velio P, Vigorelli R, Bozzani A, Castagnone D, Ranzi T, Bianchi Porro A: The effect of dietary guar on serum cholesterol, intestinal transit and fecal output in man. Am J Gastroenterol 81:123-125, 1986
41. Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V: Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. J Parent Ent Nutr 18:846-490, 1994